India mandates sterilisation subcontractor names on medical device labels

India's regulatory authorities have introduced a requirement for medical device manufacturers to disclose the names of sterilisation subcontractors on product labels, marking a new compliance obligation for the sector. The mandate aims to enhance traceability and accountability in the sterilisation process, a critical step in medical device manufacturing.

Domestic medtech firms have voiced concerns that the labeling requirement could complicate their operations and potentially disadvantage Indian manufacturers in global markets. Industry representatives argue that foreign competitors may not face equivalent disclosure mandates in their home markets, creating an uneven playing field for export-oriented Indian companies.

The sterilisation process is essential for ensuring that medical devices are free from microorganisms before reaching patients. By requiring disclosure of subcontractors involved in this process, regulators aim to establish clearer responsibility chains and facilitate faster responses in case of quality issues or recalls.

Manufacturers will need to update their labeling practices and supply chain documentation to comply with the new directive. The timing and implementation details of the mandate are expected to provide affected companies with transition periods to align their operations with the fresh requirements.